Cipher Pharmaceuticals Inc.
CPH.TO
Get informed when a big investor buys or sells
+ FollowMarket Cap$244.52M
Close$
Share Statistics
| Market cap | $244.52 Million |
|---|---|
| Enterprise Value | $248.31 Million |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | 21.16% |
|---|---|
| Return on Assets | 18.51% |
| Return on Invested Capital | 13.93% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 5.03 |
| Enterprise Value to EBIT | 12.99 |
| Enterprise Value to Net Income | 8 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Cipher Pharmaceuticals, Inc.
5 employees
CEO: Craig Mull Cipher Pharmaceuticals, Inc. engages as a specialty pharmaceutical company, which have diversified portfolio of commercial and early to late-stage products. It acquires products that fulfill unmet medical needs, manages the required clin...